Mild mesangial proliferative IgA nephropathy with and without minimal change disease.
Wang S, Huang B, Wang P, Liu Y, Liu Y, Chen H, Zhang J.
Clin Exp Med. 2023 Dec;23(8):5367-5376. doi: 10.1007/s10238-023-01184-0. Epub 2023 Oct 5.
Steroid-sensitive recurrent mesangial proliferative glomerulonephritis with monoclonal IgG deposits.
Nomura K, Miyatake N, Okada K, Hayashi N, Fujimoto K, Adachi H, Furuichi K, Shimizu A, Yokoyama H.
CEN Case Rep. 2021 May;10(2):308-313. doi: 10.1007/s13730-020-00562-x. Epub 2021 Jan 4.
Expression and clinical significance of thrombospondin-1 and plasminogen activator inhibitor-1 in patients with mesangial proliferative glomerulonephritis.
Pan C, Zhou C, Shan A, Chen N.
Ann Palliat Med. 2020 Sep;9(5):3187-3193. doi: 10.21037/apm-20-1291. Epub 2020 Aug 31.
Mesangial proliferative glomerulonephritis. Natural history and effects of dextran sulfate.
Dohi K, Nakamoto Y, Ishikawa H.
Jpn J Med. 1987 Feb;26(1):50-7. doi: 10.2169/internalmedicine1962.26.50.
Pathological regression by angiotensin II type 1 receptor blockade in patients with mesangial proliferative glomerulonephritis.
Ohtake T, Oka M, Maesato K, Mano T, Ikee R, Moriya H, Kobayashi S.
Hypertens Res. 2008 Mar;31(3):387-94. doi: 10.1291/hypres.31.387.
The cyclin-dependent kinase inhibitor p21 limits murine mesangial proliferative glomerulonephritis.
Monkawa T, Pippin J, Yo Y, Kopp JB, Alpers CE, Shankland SJ.
Nephron Exp Nephrol. 2006;102(1):e8-18. doi: 10.1159/000088311. Epub 2005 Sep 19.
Associations Between Kidney Histopathologic Lesions and Incident Cardiovascular Disease in Adults With Chronic Kidney Disease.
Buckley LF, Schmidt IM, Verma A, Palsson R, Adam D, Shah AM, Srivastava A, Waikar SS.
JAMA Cardiol. 2023 Apr 1;8(4):357-365. doi: 10.1001/jamacardio.2023.0056.
Diffuse proliferative glomerulonephritis--how many types?
Pound SE, MacDonald MK, Thomson D.
Histopathology. 1987 Mar;11(3):227-43. doi: 10.1111/j.1365-2559.1987.tb02629.x.
Non-IgA mesangial proliferative glomerulonephritis. Clinical and pathological analysis of 77 cases.
Chen YP, Wang HY, Zou WZ.
Chin Med J (Engl). 1989 Jul;102(7):510-5.
Proliferative glomerulonephritis with monoclonal IgM deposits without Waldenstrom's macroglobulinemia: case report and review of the literature.
Yahata M, Nakaya I, Takahashi S, Sakuma T, Sato H, Soma J.
Clin Nephrol. 2012 Mar;77(3):254-60. doi: 10.5414/cn107230.
